Q2 2019 Holdings
Filed 2019-08-14 | 104 holdings | $484.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $180.9M | 6,706,268 | 37.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $64.7M | 2,587,953 | 13.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $54.5M | 473,475 | 11.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $44.6M | 11,521,102 | 9.2% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $41.5M | 1,543,790 | 8.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $35.4M | 3,153,923 | 7.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $18.5M | 3,085,458 | 3.8% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $15.1M | 600,000 | 3.1% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $13.8M | 285,000 | 2.8% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $8.8M | 330,738 | 1.8% |
| Cryolife Inc(AORT) | COM | 228903100 | $1.5M | 50,000 | 0.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.4M | 53,879 | 0.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $339.7K | 4,023,862 | 0.1% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $303.8K | 5,775,726 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $298.7K | 2,899,606 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $292.2K | 11,915,127 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $268.4K | 21,509,486 | 0.1% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $187.6K | 9,822,118 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $167.6K | 3,507,223 | 0.0% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $155.8K | 6,007,746 | 0.0% |
| Amarin Corporation PLC | SPONS ADR NEW | 023111206 | $120.2K | 6,201,269 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $114.4K | 1,212,731 | 0.0% |
| Quotient LTD | SHS | G73268107 | $100.9K | 10,789,054 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $80.9K | 1,380,171 | 0.0% |
| Retrophin Inc | COM | 761299106 | $75.8K | 3,772,582 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $73.8K | 1,137,765 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $55.2K | 1,100,511 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $54.9K | 1,704,330 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $52.1K | 2,368,890 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $50.1K | 3,553,060 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $49.9K | 970,997 | 0.0% |
| Merit Medical Systems Inc(MMSI) | COM | 589889104 | $48.7K | 817,209 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $48.1K | 1,038,390 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $48.1K | 5,455,243 | 0.0% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $39.6K | 3,410,412 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $36.7K | 3,135,199 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $36.2K | 2,905,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $35.8K | 350,000 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $33.2K | 385,982 | 0.0% |
| Vapotherm Inc | COM | 922107107 | $32.3K | 1,404,470 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $31.6K | 1,343,491 | 0.0% |
| Neptune Wellness Solutions Inc | COM | 64079L105 | $30.0K | 8,891,452 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $29.7K | 3,609,084 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $29.7K | 1,977,412 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $27.7K | 1,260,528 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $27.7K | 3,862,821 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $27.1K | 13,165,746 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $26.5K | 2,204,641 | 0.0% |
| Protagonist Therapeutics Inc | COM | 4366E1029 | $25.1K | 2,071,297 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM | 91822J103 | $24.6K | 25,951,556 | 0.0% |